OT-004

N/A

Report date: 2023/10/26 16:57:55

Base Information

Drug NameOT-004
Drug Alias NameOT-004
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionX-linked retinitis pigmentosa GTPase regulator-interacting protein 1 gene transference
TargetsX-linked retinitis pigmentosa GTPase regulator-interacting protein 1
Therapy Area/IndicationsRetinal Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOdylia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOdylia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRetinal Dystrophies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A